| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029046 |
| Receipt No. | R000033223 |
| Official scientific title of the study | The retrospective study of inhibitory effect on optic disc hemorrhage of anti glaucoma drugs |
| Date of disclosure of the study information | 2017/09/07 |
| Last modified on | 2017/09/07 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The retrospective study of inhibitory effect on optic disc hemorrhage of anti glaucoma drugs | |
| Title of the study (Brief title) | Inhibitory effect of anti glaucoma drugs on optic disc hemorrhage | |
| Region |
|
|
| Condition | |||
| Condition | Glaucoma | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This retrospective study aims to evaluate the effect of anti glaucoma drugs excluded 0.1% brimonidine on optic disc hemorrhage(DH) in the glaucoma patients with a history of DH. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Comparison with the frequency of DH before and after addition of anti glaucoma ophthalmic solution |
| Key secondary outcomes | 1) Ratio of frequency of DH occurence
2) Intraocular pressure with Goldmann applanation tonometer |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients being treated for more than two years.
2)Patients administered with additional anti glaucoma ophthalmic solution for more than one year. 3)Patients with optic disc hemorrhage before administration of additional anti glaucoma ophthalmic solution 4)Patients who had no addition or change with glaucoma therapeutic drugs in the peroid between the day of anti glaucoma ophthalmic solution addition and the end date of observation period. (If both eyes constitute indication, worse eye is chosen.) |
|||
| Key exclusion criteria | 1)Patients with retinal disease.
2)Patients with corneal opacity. 3)Patients who underwent LASIK surgery. 4)Patients who are undergoing glaucoma surgery within the observation period since the addition of anti glaucoma ophthalmic solution 5) Patients who were inability to take visual field test in accuracy 6)Patients with MD value -25dB or below. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Koji Nitta |
| Organization | Fukui-ken Saiseikai Hospital |
| Division name | Ophthalmology |
| Address | Funabashi7-1, Wadanakamachi, Fukui city, Fukui |
| TEL | 0776-23-1111 |
| nitta.koji7001@fukui.saiseikai.or.jp | |
| Public contact | |
| Name of contact person | Koji Nitta |
| Organization | Fukui-ken Saiseikai Hospital |
| Division name | Ophthalmology |
| Address | Funabashi7-1, Wadanakamachi, Fukui city, Fukui |
| TEL | 0776-23-1111 |
| Homepage URL | |
| nitta.koji7001@fukui.saiseikai.or.jp | |
| Sponsor | |
| Institute | Fukui-ken Saiseikai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Senju Pharmaceutical Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Shimamoto Ophthalmology Clinic (Fukui) |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福井県済生会病院 島本眼科医院 Fukui-ken Saiseikai Hospital Shimamoto Ophthalmology Clinic (Fukui) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | nothing |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033223 |